{
  "report_rows": [
    {
      "kpi": "Q2 organic sales growth",
      "prediction": "IN-LINE",
      "answer": "pred ~5.6% vs. cons 5.3%.",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.85 vs. cons $0.83.",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 WATCHMAN organic sales growth",
      "prediction": "MISS",
      "answer": "pred ~10.5% vs. cons 13.0%.",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 organic sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~7.25% vs. cons 7.20% (FY2026).",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$3.38 vs. cons $3.38 (FY2026).",
      "confidence": "HIGH"
    },
    {
      "kpi": "Q3 organic sales growth",
      "prediction": "LOWER",
      "answer": "guide ~6.7% vs. cons 7.2% (Q3 2026).",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 adjusted EPS",
      "prediction": "LOWER",
      "answer": "guide ~$0.84 vs. cons $0.85 (Q3 2026).",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 4.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 2.0,
  "day5_path": "FADE",
  "day5_rationale": "A ~$0.02 EPS beat versus $0.83 and maintained FY EPS midpoint of ~$3.38 versus $3.38 should initially relieve fears of another reset, but a softer Q3 organic-growth guide of ~6.7% versus 7.2% and WATCHMAN growth of ~10.5% versus 13.0% should pull 2026H2 and 2027 revenue estimates lower.",
  "day5_confidence": "MEDIUM"
}